Gut microbiota depletion from early adolescence alters anxiety and depression-related behaviours in male mice with Alzheimer-like disease

Sci Rep. 2021 Nov 25;11(1):22941. doi: 10.1038/s41598-021-02231-0.

Abstract

The gut-microbiota-brain axis plays an important role in stress-related disorders, and dysfunction of this complex bidirectional system is associated with Alzheimer's disease. This study aimed to assess the idea that whether gut microbiota depletion from early adolescence can alter anxiety- and depression-related behaviours in adult mice with or without Alzheimer-like disease. Male C57BL/6 mice were treated with an antibiotic cocktail from weaning to adulthood. Adult mice received an intracerebroventricular injection of amyloid-beta (Aβ)1-42, and were subjected to anxiety and depression tests. We measured, brain malondialdehyde and glutathione following anxiety tests, and assessed brain oxytocin and the hypothalamic-pituitary-adrenal (HPA) axis function by measuring adrenocorticotrophic hormone (ACTH) and corticosterone following depression tests. Healthy antibiotic-treated mice displayed significant decreases in anxiety-like behaviours, whereas they did not show any alterations in depression-like behaviours and HPA axis function. Antibiotic treatment from early adolescence prevented the development of anxiety- and depression-related behaviours, oxidative stress and HPA axis dysregulation in Alzheimer-induced mice. Antibiotic treatment increased oxytocin in the brain of healthy but not Alzheimer-induced mice. Taken together, these findings suggest that gut microbiota depletion following antibiotic treatment from early adolescence might profoundly affect anxiety- and depression-related behaviours, and HPA axis function in adult mice with Alzheimer-like disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenocorticotropic Hormone / metabolism
  • Alzheimer Disease / drug therapy
  • Alzheimer Disease / microbiology*
  • Alzheimer Disease / physiopathology
  • Alzheimer Disease / psychology
  • Amyloid beta-Peptides
  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Anxiety / microbiology
  • Anxiety / physiopathology
  • Anxiety / prevention & control*
  • Anxiety / psychology
  • Behavior, Animal / drug effects*
  • Brain-Gut Axis*
  • Depression / microbiology
  • Depression / physiopathology
  • Depression / prevention & control*
  • Depression / psychology
  • Disease Models, Animal
  • Dysbiosis
  • Gastrointestinal Microbiome / drug effects*
  • Hypothalamo-Hypophyseal System / metabolism
  • Hypothalamo-Hypophyseal System / physiopathology*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Oxidative Stress
  • Oxytocin / metabolism
  • Peptide Fragments

Substances

  • Amyloid beta-Peptides
  • Anti-Bacterial Agents
  • Peptide Fragments
  • amyloid beta-protein (1-42)
  • Oxytocin
  • Adrenocorticotropic Hormone